Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?
作者信息
Zamarin Dmitriy
机构信息
Memorial Sloan Kettering Cancer Center, 300 East 66th Street, 1313, New York, NY 10065, USA.
出版信息
Mol Ther. 2018 Jan 3;26(1):9-12. doi: 10.1016/j.ymthe.2017.12.006. Epub 2017 Dec 15.
Abstract
摘要
相似文献
1
Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?钒：溶瘤免疫疗法耐药的万灵药？
Mol Ther. 2018 Jan 3;26(1):9-12. doi: 10.1016/j.ymthe.2017.12.006. Epub 2017 Dec 15.
2
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.多模态增强肿瘤溶瘤病毒治疗作用的钒化合物。
Mol Ther. 2018 Jan 3;26(1):56-69. doi: 10.1016/j.ymthe.2017.10.014. Epub 2017 Oct 24.
3
Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.增强肿瘤溶瘤病毒治疗作用的双吡啶钒酸盐。
Biometals. 2019 Jun;32(3):545-561. doi: 10.1007/s10534-019-00200-9. Epub 2019 Jun 17.
4
From virotherapy to oncolytic immunotherapy: where are we now?从病毒疗法到溶瘤免疫疗法：我们现在在哪里？
Curr Opin Virol. 2015 Aug;13:93-100. doi: 10.1016/j.coviro.2015.06.005. Epub 2015 Jun 26.
5
Development of oncolytic virotherapy: from genetic modification to combination therapy.溶瘤病毒治疗的发展：从基因修饰到联合治疗。
Front Med. 2020 Apr;14(2):160-184. doi: 10.1007/s11684-020-0750-4. Epub 2020 Mar 7.
6
Oncolytic Immunotherapy.溶瘤免疫疗法
Surg Oncol Clin N Am. 2019 Jul;28(3):419-430. doi: 10.1016/j.soc.2019.02.007. Epub 2019 Apr 5.
7
Two roads for oncolytic immunotherapy development.肿瘤溶瘤免疫治疗的两条发展道路。
J Immunother Cancer. 2019 Feb 1;7(1):26. doi: 10.1186/s40425-019-0515-2.
8
Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors.利用联合免疫疗法和溶瘤病毒疗法治疗实体瘤的潜力。
Ann Surg Oncol. 2022 Feb;29(2):762-763. doi: 10.1245/s10434-021-11059-x. Epub 2021 Nov 26.
9
Oncolytic viruses as a promising therapeutic strategy for hematological malignancies.溶瘤病毒作为血液系统恶性肿瘤有前途的治疗策略。
Biomed Pharmacother. 2021 Jul;139:111573. doi: 10.1016/j.biopha.2021.111573. Epub 2021 Apr 22.
10
Integrating oncolytic viruses in combination cancer immunotherapy.将溶瘤病毒整合到联合癌症免疫疗法中。
Nat Rev Immunol. 2018 Aug;18(8):498-513. doi: 10.1038/s41577-018-0014-6.
本文引用的文献
1
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.多模态增强肿瘤溶瘤病毒治疗作用的钒化合物。
Mol Ther. 2018 Jan 3;26(1):56-69. doi: 10.1016/j.ymthe.2017.10.014. Epub 2017 Oct 24.
2
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.随机、开放标签的 II 期研究评估了替莫唑胺联合伊匹单抗与伊匹单抗单药治疗晚期不可切除黑色素瘤患者的疗效和安全性。
J Clin Oncol. 2018 Jun 10;36(17):1658-1667. doi: 10.1200/JCO.2017.73.7379. Epub 2017 Oct 5.
3
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.溶瘤病毒疗法可促进肿瘤内T细胞浸润并改善抗PD-1免疫疗法。
Cell. 2017 Sep 7;170(6):1109-1119.e10. doi: 10.1016/j.cell.2017.08.027.
4
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.瘤内递送灭活的安卡拉改良痘苗病毒（iMVA）通过STING和Batf3依赖性树突状细胞诱导全身抗肿瘤免疫。
Sci Immunol. 2017 May 19;2(11). doi: 10.1126/sciimmunol.aal1713.
5
SHP-1: the next checkpoint target for cancer immunotherapy?SHP-1：癌症免疫疗法的下一个检查点靶点？
Biochem Soc Trans. 2016 Apr 15;44(2):356-62. doi: 10.1042/BST20150251.
6
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.替莫唑胺胶丸联合放疗治疗恶性脑胶质瘤的疗效观察
J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26.
7
Maraba virus as a potent oncolytic vaccine vector.马拉巴病毒作为一种有效的溶瘤疫苗载体。
Mol Ther. 2014 Feb;22(2):420-429. doi: 10.1038/mt.2013.249. Epub 2013 Oct 25.
8
Type I interferon is selectively required by dendritic cells for immune rejection of tumors.Ⅰ型干扰素通过树突状细胞选择性地需要用于免疫排斥肿瘤。
J Exp Med. 2011 Sep 26;208(10):1989-2003. doi: 10.1084/jem.20101158. Epub 2011 Sep 19.
9
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells.宿主 I 型干扰素信号通过 CD8α+树突状细胞对于抗肿瘤 CD8+T 细胞应答是必需的。
J Exp Med. 2011 Sep 26;208(10):2005-16. doi: 10.1084/jem.20101159. Epub 2011 Sep 19.
10
Inhibition of acid, alkaline, and tyrosine (PTP1B) phosphatases by novel vanadium complexes.新型钒配合物对酸、碱和酪氨酸（PTP1B）磷酸酶的抑制作用。
J Inorg Biochem. 2010 Mar;104(3):274-81. doi: 10.1016/j.jinorgbio.2009.12.001. Epub 2009 Dec 11.
Zotero 插件